To: All persons and/or entities who purchased common stock in Textura Corporation [TXTR] during the period from June 7, 2013 and January 7, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Fred Kelsey v. Patrick J. Allin, et al., Case No. 14-cv-7837 (N.D.Ill.), United States District Court for the Northern District of Illinois. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is OCTOBER 23, 2017. If you […]

To: All persons and/or entities who purchased common stock in Salix Pharmaceuticals, Ltd. [SLXP] during the period from Nov 8, 2013 to Nov 6, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as In re Salix Pharmaceuticals, Ltd., Case No. 14 Civ. 8925 (KMW) , United States District Court for the Southern District of New York. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is AUGUST 9, […]

To: All persons and/or entities who purchased common stock in Geron Corporation [GERN] during the period from Dec 10, 2012 to Mar 11, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Geron Corporation Securities. Litigation,  Civil Action No. 3:14-cv-01224-CRB, United States District Court for the Northern District of California. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is July 11, 2017. If you have any questions about […]

To: All persons and/or entities who purchased common stock in Energy Recovery [ERII] during the period from Mar 7, 2013 to Mar 5, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as Energy Recovery, Inc. Securities Litigation, Civil Action No. 3:15-cv-00265-EMC, United States District Court for the Northern District of California. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is August 4, 2017. If you have […]

To: All persons and/or entities who purchased common stock in Molycorp, Inc. [NYSE: MCP] during the period from February 21, 2012 through October 15, 2013, inclusive, and were damaged thereby; a settlement has been announced in the securities litigation known as In re Molycorp, Inc. Securities Litigation , Civil Action No. 13-Civ-5697 (PAC) , United States District Court for the Southern District of New York. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim […]

To: All persons and/or entities who purchased common stock in MARD, INC. f/k/a KIOR, INC. (“KIOR”) during the period from June 24, 2011 to March 17, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Carlton, et al., v. Cannon, et al., Case No. 4:15-cv-00012 (S.D. Tex.), and the severed action Berry v. KiOR, Inc., et al., Case No. 4:13-cv-02443 (S.D.Tex.) (which was the name of the case when it was originally filed) (collectively, the “Actions”). For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed […]

To: All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District Court for the Northern District of California.. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is April 6, 2017.  The […]